探花合集 Appoints Dr. Behzad Mahdavi as Vice President of Open Innovation, Biologics, Cell and Gene Therapy
SOMERSET, N.J. 鈥 November 19, 2020 鈥 探花合集, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Behzad Mahdavi, Ph.D., MBA, as Vice President of Open Innovation, Biologics, Cell and Gene Therapy. In this new role, reporting to Julien Meissonnier, 探花合集鈥檚 Chief Scientific Officer, Dr. Mahdavi will join a team of experts in 探花合集鈥檚 Science and Technology Group that works with customers and external innovators in both small and large molecules, to accelerate the adoption of new development and drug delivery technologies, and scalable manufacturing processes and techniques.
With over 20 years鈥 experience in developing and implementing impactful growth strategies in the biopharmaceutical industries, Dr. Mahdavi joins 探花合集 after a 13-year career at Lonza, where he held the role of Vice President Strategic Innovation & Alliances, and various board-level positions at other innovative companies. Prior to joining Lonza, he was Chief Executive Officer of SAM Electron Technologies, a venture capital-backed company in the life sciences field. He holds a doctorate in chemistry from the University of Sherbrooke, Canada, and also has a master鈥檚 in business administration from the University of Quebec in Montreal.
鈥淎s a company, 探花合集 continues to invest in the rapidly evolving and growing areas of cell and gene therapies and next-generation biopharmaceuticals, which are redefining the landscape of treating diseases,鈥 commented Mr. Meissonnier. 鈥淚 am delighted to welcome Behzad to 探花合集, as he brings significant experience in leveraging accelerated innovation with strategic external sourcing, to further strengthen our strategy of delivering the therapies of tomorrow to patients faster, and more efficiently.鈥
ABOUT CATALENT
探花合集 is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. 探花合集 employs approximately 14,000 people including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. 探花合集 is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com